|
Global Medical REIT, 7.50% Series A Cumulative Redeemable Preferred Stock
Ticker Symbol: GMRE-A CUSIP: 37957W203 Exchange: NYSE
QUANTUMONLINE.COM SECURITY DESCRIPTION: Global Medical REIT, 7.50% Series A Cumulative Redeemable Preferred Stock, liquidation preference $25 per share, redeemable at the issuer's option on or after 9/15/2022 at $25 per share plus accrued and unpaid dividends, and with no stated maturity. Cumulative distributions of 7.50% per annum ($1.875 per annum or $0.46875 per quarter) will be paid quarterly on 1/31, 4/30, 7/31 & 10/31 to holders of record on the record date which will be 1/15, 4/15, 7/15 & 10/15 respectively (NOTE: the ex-dividend date is one business day prior to the record date). Upon the occurrence of a change of control the company will have the option within 120 days to redeem the preferred shares at $25 per share plus accrued and unpaid dividends. If the company has exercised their redemption right, the holders will NOT have the following conversion right. Upon the occurrence of a change of control, and the company has NOT provided notice that they intend to redeem the preferred shares, the holder will have the right to convert the preferred shares into common shares under certain circumstances (see the prospectus for details). Dividends paid by preferreds issued by REITs are NOT eligible for the preferential 15% to 20% tax rate on dividends and are also NOT eligible for the dividend received deduction for corporate holders. This security was not rated by Moody’s or S&P at the time of its IPO. In regard to the payment of dividends and upon liquidation, the preferred shares rank junior to the company's senior debt, equally with other preferreds of the company, and senior to the common shares of the company. See the IPO prospectus for further information on the preferred stock by clicking on the ‘Link to IPO Prospectus’ provided below.
|
Go to Parent Company's Record (GMRE)
IPO - 9/13/2017 - 2.70 Million Shares @ $25.00 /share.
Link to IPO Prospectus
Previous Ticker Symbol: GLLFP Changed: 9/21/2017
Market Value $ Million
Company's Online Information Links
|
Company's Online SEC EDGAR Filings |
Company's Email Address Links |
Address and Phone Numbers |
Address: 7373 Wisconsin Avenue, Suite 800,, Bethesda, MD 20814 |
Main Phone Number |
202-524-6851 |
Fax Number |
Not Available |
Investor Relations
Evelyn Infurna, ICR Inc.
|
203-682-8265
|
CEO - Jeffrey Busch |
CFO - Robert J. Kiernan |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|